Stewarding the Costly Antibiotic: Considerations for Dalbavancin

Clin Infect Dis. 2021 Oct 5;73(7):e1443-e1444. doi: 10.1093/cid/ciaa1730.

Authors

P Brandon Bookstaver^{1

2}, Alex Milgrom³

Affiliations

¹ University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
² Prisma Health Richland, Columbia, South Carolina, USA.
³ Division of Infectious Diseases, Department of Internal Medicine, Prisma Health Richland/University of South Carolina Medical Group, Columbia, South Carolina, USA.

PMID: 33211844
DOI: 10.1093/cid/ciaa1730

No abstract available

Keywords: lipoglycopeptide; outpatient parenteral antibiotic therapy; stewardship.

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Humans
Skin Diseases, Bacterial* / drug therapy
Teicoplanin / analogs & derivatives

Substances

Anti-Bacterial Agents
Teicoplanin
dalbavancin